Mitigation of hypoglycemia during Ramadan using the flash glucose monitoring system following dose adjustment of insulin and sulphonylurea in patients taking multiple glucose-lowering therapies (The PROFAST-IT Study)

and HypothesisPatients with type-2 diabetes mellitus (T2DM) on multiple glucose-lowering therapies who fast during Ramadan are at increased risk of hypoglycemia. We have assessed the utility of the flash glucose monitoring system after adjusting the dose of insulin and sulphonylureas to mitigate the risk of hypoglycemia in patients with T2DM who fast during Ramadan.

Source: Diabetes Research and Clinical Practice - December 11, 2020 Category: Endocrinology Authors: Tarik Elhadd, Mohamed Bashir, Khaled A Baager, Hamda A Ali, Dabia H S Almohannadi, Zainab Dabbous, Rayaz A Malik, Abdul-Badie Abou-Samra, for the PROFAST Ramadan Study Group Source Type: research